Drug intelligence / Profile preview

Lidocream

Development stage: Unknown
Lead developer: Golden Touch
Modality: Small Molecules
Administration: Topical

Overview

Lidocream is an over-the-counter topical anesthetic cream manufactured and distributed by Golden Touch LLC. Its active ingredient is lidocaine, a small molecule local anesthetic. Available in 4%, 5%, and 10% concentrations, Lidocream is used for the temporary relief of pain and itching associated with minor burns, skin irritations, cuts, scrapes, sunburn, insect bites, and anorectal disorders. It works by stabilizing the neuronal membrane through the inhibition of ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action.

Brand names: Lidocream

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Lidocream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lidocream.

Explore the full profile